Who owns EPRX?
Institutional ownership of Eupraxia Pharmaceuticals Inc. from Form 13F, Q2 2026
68 institutional managers reported holding Eupraxia Pharmaceuticals Inc. (EPRX) in Form 13F filings for Q2 2026, with 24,811,199 shares worth $164M. The largest reported holder was Beutel, Goodman & Co Ltd. Managers that filed both quarters added a net 1,387,273 shares (+6.3%). 16 opened new positions and 5 sold out.
- Funds holding
- 68
- Value held
- $164M
- New / sold out
- 16 / 5
- Net shares, same filers
- +6.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of EPRX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | $23.8M | 14.6% | 3,627,864 | Trimmed |
| Affinity Asset Advisors, LLC | $10.9M | 6.7% | 1,650,000 | Added |
| Balyasny Asset Management L.P. | $8.9M | 5.4% | 1,350,015 | Unchanged |
| Vivo Capital, LLC | $8.9M | 5.4% | 1,350,000 | Unchanged |
| Scotia Capital Inc. | $8.8M | 5.4% | 1,343,726 | Added |
| PFM Health Sciences, LP | $8.0M | 4.9% | 1,210,661 | Added |
| Great Point Partners LLC | $7.9M | 4.8% | 1,200,000 | Unchanged |
| Jupiter Topco LLC | $6.9M | 4.2% | 1,046,000 | First report |
| Rubric Capital Management LP | $5.7M | 3.5% | 867,424 | Added |
| Ikarian Capital, LLC | $5.4M | 3.3% | 809,741 | Trimmed |
| Woodline Partners LP | $4.9M | 3.0% | 746,864 | Added |
| Point72 Asset Management, L.P. | $4.8M | 2.9% | 730,284 | Trimmed |
| Ameriprise Financial Inc | $4.7M | 2.9% | 711,024 | Added |
| Redmile Group, LLC | $4.0M | 2.5% | 611,400 | Trimmed |
| Seven Fleet Capital Management LP | $4.0M | 2.5% | 610,785 | Added |
| UBS Group AG | $3.4M | 2.1% | 519,211 | Trimmed |
| Citadel Advisors LLC | $3.3M | 2.0% | 502,011 | Added |
| Millennium Management LLC | $2.9M | 1.8% | 441,586 | New |
| Alyeska Investment Group, L.P. | $2.5M | 1.5% | 375,000 | Unchanged |
| Picton Mahoney Asset Management | $2.4M | 1.5% | 360,878 | New |
| Velan Capital Investment Management LP | $2.3M | 1.4% | 352,000 | Unchanged |
| Jane Street Group, LLC | $2.2M | 1.3% | 329,053 | Added |
| Aisling Capital Management LP | $2.1M | 1.3% | 325,000 | Unchanged |
| SummitTX Capital, L.P. | $2.1M | 1.3% | 318,784 | Trimmed |
| Royal Bank of Canada | $2.1M | 1.3% | 311,435 | Added |
Share of 13F holdings is each fund's shares as a share of the 24,811,199 EPRX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- PFM Health Sciences, LP Added+$4.4M
- Millennium Management LLC New+$2.9M
- Picton Mahoney Asset Management New+$2.4M
- Woodline Partners LP Added+$2.0M
- Jane Street Group, LLC Added+$1.9M
- Citadel Advisors LLC Added+$1.8M
- Orbimed Advisors LLC New+$1.8M
- DAFNA Capital Management LLC New+$1.5M
- Two Sigma Investments, LP Added+$1.4M
- Ameriprise Financial Inc Added+$1.2M
Biggest sellers in Q2 2026
- Squadron Capital Management LLC Sold out-$4.9M
- Ally Bridge Group (NY) LLC Trimmed-$2.7M
- Ikarian Capital, LLC Trimmed-$2.7M
- DV Trading LLC Sold out-$2.0M
- UBS Group AG Trimmed-$1.6M
- Point72 Asset Management, L.P. Trimmed-$1.6M
- Boothbay Fund Management, LLC Trimmed-$735K
- Acadian Asset Management LLC Sold out-$671K
- Hudson Bay Capital Management LP Sold out-$669K
- Redmile Group, LLC Trimmed-$586K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $27.6M and sold $19.2M; 21 added and 17 trimmed.
Schedule 13D and 13G filings on EPRX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-11-14Beutel, Goodman & Co Ltd. SCHEDULE 13G filed by Eupraxia Pharmaceuticals Inc.Schedule 13G
- 2025-11-13MANCHESTER MANAGEMENT CO LLC SCHEDULE 13G filed by Eupraxia Pharmaceuticals Inc.Schedule 13G
Questions about EPRX ownership
- Who owns EPRX stock?
- 68 institutional investment managers reported EPRX positions in their Form 13F filings for Q2 2026, holding 24,811,199 shares worth $164M in total. Beutel, Goodman & Co Ltd. reported the largest position.
- Are funds buying or selling EPRX?
- In Q2 2026, 16 managers opened new EPRX positions, 21 added, 17 trimmed and 5 sold out. Managers that filed in both quarters added a net 1,387,273 shares.
- How current is this EPRX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to EPRX by CUSIP. Options are left out. EPRX news and filings · EPRX insider trades · Top funds